Capitalizator.

Capitalize Yourself: Right Data. Real Growth.

Large Insider Purchases

Institutional-Scale SEC Form 4 Buy Signals

The Signal of $1M+ Conviction

When a corporate executive invests more than $1,000,000 of their own capital into company shares, it represents the highest level of conviction. These seven-figure purchases reflect management's belief in the company's future value.

Filing Date Trade Date Ticker Company Name Reporting Person Relationship Industry Type Price Qty Total, $ Owned After Change, %
2014-11-04 02:58 2014-10-31 XOOM N/A BOTHA ROELOF Director Other BUY $15.28 70,000 $1,069,733 70,000 +100.0%
2014-11-04 00:52 2014-10-30 SHLD N/A BERKOWITZ BRUCE R 10% owner Other BUY $36.45 317,000 $11,555,030 25,686,673 +1.2%
2014-11-03 20:04 2014-10-31 SONS N/A DOLAN RAYMOND P Director, Officer - CEO and President Other BUY $3.43 1,000,000 $3,425,800 4,578,674 +27.9%
2014-11-04 00:33 2014-10-28 HUN Huntsman CORP ARCHIBALD NOLAN D Director Chemicals & Allied Products BUY $23.99 450,000 $10,797,300 500,523 +890.7%
2014-11-03 19:38 2014-10-30 SCCO SOUTHERN COPPER CORP/ VELASCO GERMAN LARREA MOTA Director, Officer - Chairman of the Board Metal Mining BUY $28.51 350,000 $9,977,450 1,369,367 +34.3%
2014-11-03 19:37 2014-10-31 SCCO SOUTHERN COPPER CORP/ VELASCO GERMAN LARREA MOTA Director, Officer - Chairman of the Board Metal Mining BUY $28.29 200,000 $5,658,860 1,569,367 +14.6%
2014-11-01 03:43 2014-10-29 SIEN N/A Abingworth LLP 10% owner Other BUY $15.00 495,000 $7,425,000 2,199,012 +29.0%
2014-11-01 00:58 2014-10-29 AAMC N/A Luxor Capital Group, LP 10% owner Other BUY $550.00 5,475 $3,011,250 115,077 +5.0%
2014-10-30 15:30 2014-10-27 PRTO Protara Therapeutics, Inc. Birner Hubert Director, 10% owner Biological Products, (No Diagnostic Substances) BUY $10.00 300,000 $3,000,000 300,000 +100.0%
2014-10-30 20:34 2014-10-28 ATLS N/A COOPERMAN LEON G 10% owner Other BUY $39.44 38,600 $1,522,384 88,600 +77.2%
2014-10-30 15:23 2014-10-27 PRTO Protara Therapeutics, Inc. TVM Life Science Ventures VI GmbH & Co KG 10% owner Biological Products, (No Diagnostic Substances) BUY $10.00 300,000 $3,000,000 300,000 +100.0%
2014-10-29 22:36 2014-10-27 DOW N/A Polman Paul Director Other BUY $46.56 21,500 $1,000,980 40,720 +111.9%
2014-10-29 23:56 2014-10-27 JMP N/A Jolson Joseph A Director, Officer, 10% owner - CEO Other BUY $6.47 569,504 $3,684,805 2,215,704 +34.6%
2014-10-30 01:42 2014-10-27 PRTO Protara Therapeutics, Inc. Pharmstandard International S.A. 10% owner Biological Products, (No Diagnostic Substances) BUY $10.00 600,000 $6,000,000 600,000 +100.0%
2014-10-30 01:38 2014-10-27 PRTO Protara Therapeutics, Inc. Haines Timothy Director, 10% owner Biological Products, (No Diagnostic Substances) BUY $10.00 950,000 $9,500,000 950,000 +100.0%
2014-10-30 01:02 2014-10-27 PRTO Protara Therapeutics, Inc. Kobyzev Dmitry Director, 10% owner Biological Products, (No Diagnostic Substances) BUY $10.00 600,000 $6,000,000 600,000 +100.0%
2014-10-30 02:04 2014-10-27 PRTO Protara Therapeutics, Inc. Freund John Gordon Director, 10% owner Biological Products, (No Diagnostic Substances) BUY $10.00 200,000 $2,000,000 200,000 +100.0%
2014-10-29 22:22 2014-10-29 KYN Kayne Anderson Energy Infrastructure Fund, Inc. LINCOLN NATIONAL LIFE INSURANCE CO /IN/ 10% owner Other BUY $250,000.00 80 $20,000,000 15,000,000 +0.0%
2014-10-30 02:35 2014-10-27 PRTO Protara Therapeutics, Inc. Skyline Venture Partners Qualified Purchaser Fund IV L P 10% owner Biological Products, (No Diagnostic Substances) BUY $10.00 200,000 $2,000,000 200,000 +100.0%
2014-10-30 01:09 2014-10-27 SHLD N/A BERKOWITZ BRUCE R 10% owner Other BUY $37.60 331,600 $12,469,387 25,429,473 +1.3%
2014-10-30 04:00 2014-10-27 GRBK Green Brick Partners, Inc. Loeb Daniel S 10% owner Operative Builders BUY $5.00 1,857,704 $9,288,520 5,242,124 +54.9%
2014-10-28 21:14 2014-10-28 MASS Greenwave Technology Solutions, Inc. Fortier Stewart Director, Officer - Chief Technology Officer Wholesale-Metals Service Centers & of fices BUY $10,000.00 20,000 $200,000,000 3,685,976 +0.5%
2014-10-29 01:23 2014-10-24 AAMC N/A Luxor Capital Group, LP 10% owner Other BUY $548.14 12,850 $7,043,567 109,602 +13.3%
2014-10-29 01:35 2014-10-24 NHF NEXPOINT DIVERSIFIED REAL ESTATE TRUST DONDERO JAMES D Other Real Estate Investment Trusts BUY $10.34 120,313 $1,244,037 4,192,142 +3.0%
2014-10-28 00:38 2014-10-23 JONE N/A Jones Jonny Director, Officer, 10% owner - Chairman of the Board and CEO Other BUY $12.41 88,495 $1,098,568 1,421,928 +6.6%
2014-10-28 00:05 2014-10-24 AGCO AGCO Corporation SRINIVASAN MALLIKA Director, 10% owner Farm Machinery & Equipment BUY $45.21 45,000 $2,034,450 3,063,321 +1.5%
2014-10-28 00:14 2014-10-23 GNK GENCO SHIPPING & TRADING LTD Apollo Management Holdings GP, LLC 10% owner Deep Sea Foreign Transportation of Freight BUY $15.60 685,553 $10,692,090 8,704 +100.0%
2014-10-28 02:12 2014-10-27 PRTO Protara Therapeutics, Inc. Flynn James E 10% owner, Other Biological Products, (No Diagnostic Substances) BUY $10.00 691,713 $6,917,130 170,371 +100.0%
2014-10-25 00:08 2014-10-23 AGCO AGCO Corporation SRINIVASAN MALLIKA Director, 10% owner Farm Machinery & Equipment BUY $45.05 60,000 $2,703,000 3,018,321 +2.0%
2014-10-24 20:39 2014-10-22 IEEC N/A Wateska Jeffrey David 10% owner Other BUY $20,000.00 1,000,000 $20,000,000,000 4,000,000 +33.3%
2014-10-24 23:11 2013-08-27 RDMP N/A Sophia Co Inc. 10% owner Other BUY $2.38 841,270 $2,000,035 1,902,232 +79.3%
2014-10-24 23:23 2014-10-23 RDEN N/A Rhone Capital L.L.C. 10% owner Other BUY $17.00 78,134 $1,328,036 4,014,087 +2.0%
2014-10-24 23:18 2014-10-22 RDEN N/A Rhone Capital L.L.C. 10% owner Other BUY $16.97 72,274 $1,226,699 3,935,953 +1.9%
2014-10-25 00:21 2012-12-17 NHF NEXPOINT DIVERSIFIED REAL ESTATE TRUST DONDERO JAMES D Other Real Estate Investment Trusts BUY $7.44 205,000 $1,525,077 25,478 +100.0%
2014-10-25 00:00 2008-03-28 NHF NEXPOINT DIVERSIFIED REAL ESTATE TRUST HIGHLAND CAPITAL MANAGEMENT LP Other Real Estate Investment Trusts BUY $15.60 117,588 $1,834,249 582 +100.0%
2014-10-24 23:00 2014-10-24 TLLP N/A TESORO CORP /NEW/ Director, 10% owner Other BUY $57.47 8,700,191 $499,999,977 28,181,748 +44.7%
2014-10-25 00:01 2014-10-22 SABA N/A Emancipation Management LLC 10% owner Other BUY $13.29 80,560 $1,070,578 3,406,030 +2.4%
2014-10-24 00:04 2014-10-22 AGCO AGCO Corporation SRINIVASAN MALLIKA Director, 10% owner Farm Machinery & Equipment BUY $44.52 75,000 $3,339,083 2,958,321 +2.6%
2014-10-24 01:59 2014-10-15 ALSN Allison Transmission Holdings Inc. ValueAct Holdings, L.P. 10% owner, Other Motor Vehicle Parts & Accessories BUY $26.74 75,000 $2,005,748 19,125,204 +0.4%
2014-10-24 01:50 2014-10-21 AAMC N/A Luxor Capital Group, LP 10% owner Other BUY $594.77 45,196 $26,881,320 96,752 +87.7%
2014-10-24 01:46 2014-10-21 ATRA Atara Biotherapeutics, Inc. MARCUS JOEL S Director Biological Products, (No Diagnostic Substances) BUY $11.00 150,000 $1,650,000 908,355 +19.8%
2014-10-24 00:02 2014-10-21 SHLD N/A BERKOWITZ BRUCE R 10% owner Other BUY $35.05 259,100 $9,080,600 25,097,873 +1.0%
2014-10-24 02:36 2014-10-20 ENTG ENTEGRIS INC GMT CAPITAL CORP 10% owner Plastics Products, NEC BUY $10.83 123,600 $1,338,588 14,586,700 +0.9%
2014-10-22 21:35 2014-10-20 N/A N/A Allegheny Technologies Inc Master Pension Trust 10% owner Other BUY $19.96 79,705 $1,590,912 589,252 +15.6%
2014-10-23 00:04 2014-10-21 AGCO AGCO Corporation SRINIVASAN MALLIKA Director, 10% owner Farm Machinery & Equipment BUY $44.47 80,000 $3,557,216 2,883,321 +2.9%
2014-10-22 23:26 2014-10-20 DM N/A MCGETTRICK MARK F Director, Officer - EVP and CFO Other BUY $21.00 59,900 $1,257,900 59,900 +100.0%
2014-10-22 23:26 2014-10-20 DM N/A KOONCE PAUL D Officer - EVP Other BUY $21.00 50,000 $1,050,000 50,000 +100.0%
2014-10-22 23:26 2014-10-20 DM N/A Snow John W. Director Other BUY $21.00 50,000 $1,050,000 50,000 +100.0%
2014-10-22 23:26 2014-10-20 DM N/A FARRELL THOMAS F II Director, Officer - Chairman and CEO Other BUY $21.00 59,900 $1,257,900 59,900 +100.0%
2014-10-22 00:06 2014-10-20 AGCO AGCO Corporation SRINIVASAN MALLIKA Director, 10% owner Farm Machinery & Equipment BUY $42.99 96,557 $4,150,985 8,132,950 +1.2%
SHOW ENTRIES

Institutional Conviction in Form 4

Tracking these institutional-scale purchases allows you to follow the "smart money" when their conviction is highest. When an executive or a 10% beneficial owner commits a seven-figure sum to an open-market transaction, it bypasses the routine noise of stock-based compensation. These trades are often a precursor to major corporate developments or a signal that management views the current market valuation as significantly disconnected from the company’s internal growth trajectory. By monitoring these high-value entries, investors can align their portfolios with the capital of those who possess the most intimate understanding of a business's long-term health and potential.

Filtering the Market Noise

Our platform is designed to eliminate the noise and focus strictly on high-impact accumulation from directors and CEOs betting big on their company’s future. The SEC EDGAR database is frequently flooded with thousands of automated Form 4 filings, many of which involve small, technical, or pre-scheduled trades that offer little predictive value for the average investor. By applying a strict $1,000,000 minimum threshold, we isolate the transactions where insiders are taking substantial personal financial risk. This high-conviction filter serves as a powerful transparency tool, identifying the exact moments when corporate leadership moves away from passive ownership toward aggressive capital deployment.

UNDERSTANDING THE DATA

FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.

TRADE DATE: The actual day the insider executed the purchase or sale in the market.

INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.

OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.

CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.

TRADE TYPES DEFINITIONS

BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.

SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.

OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.